ERBB2 and breast cancer: Conversely, our analysis is based on a randomized trial dedicated to HER2-positive BC patients, including a large number of cases with HR-positive/HER2-positive BC (n = 784), all treated with standard adjuvant chemotherapy and trastuzumab.